ロード中...
Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
Anti-estrogen and anti-HER2 treatments have been among the first and most successful examples of targeted therapy for breast cancer (BC). However, the treatment of triple-negative BC (TNBC) that lack estrogen receptor expression or HER2 amplification remains a major challenge. We previously discover...
保存先:
| 出版年: | Breast Cancer Res Treat |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer US
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4869778/ https://ncbi.nlm.nih.gov/pubmed/27120467 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-016-3807-y |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|